MEDITERA TIBBI MALZEMENAYI VE TICARET AS (IST:MEDTR) Total Liabilities : ₺547 Mil (As of Sep. 2024)

View and export this data going back to 2021. Start your Free Trial

What is MEDITERA TIBBI MALZEMENAYI VE TICARET AS Total Liabilities?

MEDITERA TIBBI MALZEMENAYI VE TICARET AS's Total Liabilities for the quarter that ended in Sep. 2024 was ₺547 Mil.

MEDITERA TIBBI MALZEMENAYI VE TICARET AS's quarterly Total Liabilities declined from Mar. 2024 (₺524.38 Mil) to Jun. 2024 (₺499.05 Mil) but then increased from Jun. 2024 (₺499.05 Mil) to Sep. 2024 (₺546.99 Mil).

MEDITERA TIBBI MALZEMENAYI VE TICARET AS's annual Total Liabilities increased from Dec. 2021 (₺149.84 Mil) to Dec. 2022 (₺381.05 Mil) and increased from Dec. 2022 (₺381.05 Mil) to Dec. 2023 (₺413.18 Mil).

MEDITERA TIBBI MALZEMENAYI VE TICARET AS Total Liabilities Historical Data

The historical data trend for MEDITERA TIBBI MALZEMENAYI VE TICARET AS's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MEDITERA TIBBI MALZEMENAYI VE TICARET AS Total Liabilities Chart

MEDITERA TIBBI MALZEMENAYI VE TICARET AS Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

Get a 7-Day Free Trial

93.72

124.53

149.84

381.05

413.18

MEDITERA TIBBI MALZEMENAYI VE TICARET AS Quarterly Data
	Dec18	Dec19	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Total Liabilities	Get a 7-Day Free Trial														375.16	413.18	524.38	499.05	546.99

MEDITERA TIBBI MALZEMENAYI VE TICARET AS Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

MEDITERA TIBBI MALZEMENAYI VE TICARET AS's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	284.722	+	(45.273	+	67.651
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	15.533)
	=	413

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	1892.926	-	1479.747
	=	413

MEDITERA TIBBI MALZEMENAYI VE TICARET AS's Total Liabilities for the quarter that ended in Sep. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	403.38	+	(26.724	+	85.297
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	31.585)
	=	547

Total Liabilities	=	Total Assets (Q: Sep. 2024 )	-	Total Equity (Q: Sep. 2024 )
	=	2628.185	-	2081.198
	=	547

MEDITERA TIBBI MALZEMENAYI VE TICARET AS Total Liabilities Related Terms

Thank you for viewing the detailed overview of MEDITERA TIBBI MALZEMENAYI VE TICARET AS's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

MEDITERA TIBBI MALZEMENAYI VE TICARET AS Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » MEDITERA TIBBI MALZEME SANAYI VE TICARET AS (IST:MEDTR) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

Sokak No: 29 Tire Organize Sanayi, Ibni Melek OSB Mahallesi, TOSBI Yol 4, Bolgesi Tire, Izmir, TUR, 35900

Website

https://www.meditera.com.tr

MEDITERA TIBBI MALZEME SANAYI VE TICARET AS is engaged in the manufacture of anesthesia and intensive care circuits, the installation, operation, and design of oncology drug preparation and delivery systems, production, sales, and technical service of infusion pumps and sets, and the manufacture of biocidal products.

MEDITERA TIBBI MALZEMENAYI VE TICARET AS Headlines

No Headlines